These results together with the observed reduction of tumor growth in Lyve-1 knockout mice support our postulated theory that sLYVE-1 acts as a decoy receptor for LMW-HA thereby inhibiting tumor cell proliferation in vivo and in vitro. Here, LYVE1 is linked to neoplasm.